The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.24

Today's change0.00 0.00%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
 

Meridian Bioscience Inc

Nasdaq: VIVO
Last

(U.S.) $19.24

Today's change0.00 0.00%
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.

Meridian Bioscience Inc unchanged

Meridian Bioscience Inc is unchanged Friday sitting at (U.S.)$19.24. Over the last five days, shares have gained 0.58%, but are down 6.24% for the last year to date. Shares have underperformed the S&P 500 by 8.38% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $19.24
  • High--
  • Low--
  • Bid / Ask(U.S.) $17.20 / (U.S.) $20.55
  • YTD % change-6.24%
  • Volume0
  • Average volume (10-day)216,428
  • Average volume (1-month)217,824
  • Average volume (3-month)220,197
  • 52-week range(U.S.) $16.60 to (U.S.) $21.49
  • Beta1.08
  • Trailing P/E23.13×
  • P/E 1 year forward22.37×
  • Forward PEG1.40×
  • Indicated annual dividend(U.S.) $0.80
  • Dividend yield4.16%
  • Trailing EPS(U.S.) $0.83
Updated August 26 4:00 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.00%Sector:HealthcareIndustry:Medical Equipment, Supplies & Distribution
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015
Revenue51514747
Total other revenue--------
Total revenue51514747
Gross profit33343230
Total cost of revenue18181617
Total operating expense37363434
Selling / general / administrative16151514
Research & development4333
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)0------
Other operating expenses, total--------
Operating income14151413
Interest income (expense), net non-operating00----
Gain (loss) on sale of assets--------
Other--------
Income before tax13151413
Income after tax9998
Income tax, total5655
Net income9998
Total adjustments to net income--------
Net income before extra. items9998
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items9998
Inc. avail. to common incl. extra. items9998
Diluted net income9998
Dilution adjustment--0----
Diluted weighted average shares42424242
Diluted EPS excluding extraordinary itemsvalue per share0.210.210.210.20
Dividends per sharevalue per share0.200.200.200.20
Diluted normalized EPSvalue per share0.210.210.210.20